陇神戎发拟定增募资近5亿元 “扩产”宣肺止嗽合剂

新京报01-07

新京报讯（记者张秀兰）陇神戎发1月5日对外公告，拟向特定对象发行A股股票募资4.86亿元，将主要用于甘肃普安制药股份有限公司年产5000万盒（3亿支）宣肺止嗽合剂等液体制剂生产线升级改造项目。　　本次发行对象为包括陇神戎发控股股东甘肃药业集团及其一致行动人丝路基金在内的不超过35名特定投资者，其中甘肃药业集团拟认购数量不超过本次发行新股数量的30.79%，认购金额不超过1.5亿元，丝路基金拟认购...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2401869471?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-01-07 20:34","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2401869471","market":"sg","top_or_hot":-1,"title":"陇神戎发拟定增募资近5亿元 “扩产”宣肺止嗽合剂","media":"新京报","content":"<div>\n<p>新京报讯（记者张秀兰）陇神戎发1月5日对外公告，拟向特定对象发行A股股票募资4.86亿元，将主要用于甘肃普安制药股份有限公司年产5000万盒（3亿支）宣肺止嗽合剂等液体制剂生产线升级改造项目。\n　　本次发行对象为包括陇神戎发控股股东甘肃药业集团及其一致行动人丝路基金在内的不超过35名特定投资者，其中甘肃药业集团拟认购数量不超过本次发行新股数量的30.79%，认购金额不超过1.5亿元，丝路基金拟认购...</p>\n\n<a href=\"https://finance.sina.com.cn/jjxw/2024-01-07/doc-inaateru9974021.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>陇神戎发拟定增募资近5亿元 “扩产”宣肺止嗽合剂</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n陇神戎发拟定增募资近5亿元 “扩产”宣肺止嗽合剂\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-07 20:34 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/jjxw/2024-01-07/doc-inaateru9974021.shtml><strong>新京报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>新京报讯（记者张秀兰）陇神戎发1月5日对外公告，拟向特定对象发行A股股票募资4.86亿元，将主要用于甘肃普安制药股份有限公司年产5000万盒（3亿支）宣肺止嗽合剂等液体制剂生产线升级改造项目。\n　　本次发行对象为包括陇神戎发控股股东甘肃药业集团及其一致行动人丝路基金在内的不超过35名特定投资者，其中甘肃药业集团拟认购数量不超过本次发行新股数量的30.79%，认购金额不超过1.5亿元，丝路基金拟认购...</p>\n\n<a href=\"https://finance.sina.com.cn/jjxw/2024-01-07/doc-inaateru9974021.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0132","symbol_name":"高送转概念","start_time":0,"source_url":"https://finance.sina.com.cn/jjxw/2024-01-07/doc-inaateru9974021.shtml","article_id":"2401869471","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-01-07/doc-inaateru9974021.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2401869471","pubTimestamp":1704630840,"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"新京报讯 陇神戎发1月5日对外公告，拟向特定对象发行A股股票募资4.86亿元，将主要用于甘肃普安制药股份有限公司年产5000万盒（3亿支）宣肺止嗽合剂等液体制剂生产线升级改造项目。　　上市募集资金扣除发行费用后将主要用于普安制药年产5000万盒（3亿支）宣肺止嗽合剂等液体制剂生产线升级改造项目、甘肃陇神戎发药业股份有限公司三化改造及合剂生产线配套建设项目、补充流动资金及偿还贷款。智能定投、条件单、个股雷达……","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300534":"陇神戎发","BK0132":"高送转概念","BK0239":"医药制造","BK0056":"扶贫"},"translate_title":"Longshen Rongfa plans to raise nearly 500 million yuan to \"expand production\" Xuanfei Zhisou Mixture","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300534":1},"content_text":"新京报讯（记者张秀兰）陇神戎发1月5日对外公告，拟向特定对象发行A股股票募资4.86亿元，将主要用于甘肃普安制药股份有限公司年产5000万盒（3亿支）宣肺止嗽合剂等液体制剂生产线升级改造项目。\n　　本次发行对象为包括陇神戎发控股股东甘肃药业集团及其一致行动人丝路基金在内的不超过35名特定投资者，其中甘肃药业集团拟认购数量不超过本次发行新股数量的30.79%，认购金额不超过1.5亿元，丝路基金拟认购数量为本次发行新股数量的7.11%，认购金额不超过3454.02万元。\n　　上市募集资金扣除发行费用后将主要用于普安制药年产5000万盒（3亿支）宣肺止嗽合剂等液体制剂生产线升级改造项目（2.99亿元）、甘肃陇神戎发药业股份有限公司三化改造及合剂生产线配套建设项目（4729.04万元）、补充流动资金及偿还贷款（1.4亿元）。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：王其霖","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2401869471"}